Source link : https://newshealth.biz/health-news/ema-backs-first-fcrn-inhibitor-for-myasthenia-gravis/
In clinical trials, Imaavy plus standard therapy improved muscle strength and daily function in adults and adolescents with generalized myasthenia gravis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ema-backs-first-fcrn-inhibitor-myasthenia-gravis-2025a1000p7b?src=rss Author : Publish date : 2025-09-22 15:29:00 Copyright for syndicated content belongs to the linked Source.
The post EMA Backs First FcRn Inhibitor for Myasthenia Gravis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-22 15:29:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8